Related Experiment Video
Updated: Jul 6, 2026
07:28
Auricular Point Acupressure Therapy: A Safe and Effective Treatment for Postsurgical Abortion Recovery
Published on: February 3, 2026
Misoprostol and first trimester pregnancy termination.
X Grapsas1, V Liberis, G Vassaras
1Department of Obstetrics and Gynecology, Democritus University of Thrace, General Hospital of Alexandroupolis, Alexandroupolis, Greece.
Clinical and Experimental Obstetrics & Gynecology
|April 9, 2008
Summary
Single-dose vaginal misoprostol effectively terminates early pregnancies. This study shows a 74.3% abortion rate within 24 hours, offering a viable medical option for first-trimester pregnancy termination.
Area of Science:
- Reproductive Medicine
- Pharmacology
Background:
- First-trimester pregnancy termination is a common medical procedure.
- Medical management offers an alternative to surgical interventions.
Purpose of the Study:
- To evaluate the efficacy of a single vaginal dose of 800 mcg misoprostol for first-trimester pregnancy termination.
- To assess outcomes without routine post-expulsion curettage.
Main Methods:
- 113 women aged 16-44 received 800 mcg vaginal misoprostol.
- Participants were divided into two groups based on gestational age (up to 9 weeks and up to 12 weeks).
Main Results:
- Successful abortion occurred within 24 hours in 74.3% of cases.
- The mean induction-abortion interval was 5.9 ± 1.7 hours.
- No significant differences in success rates or side-effects were observed between gestational age groups.
Conclusions:
- Vaginal misoprostol is an effective agent for first-trimester medical termination.
- A single dose is sufficient for a significant success rate, minimizing the need for further intervention.
Related Concept Videos
01:20Drugs for Peptic Ulcer Disease: Prostaglandin Analogs as Mucosal Protective Agents
The gastric mucosa produces prostaglandins E2 (PGE2) and prostacyclin (PGI2), crucial in maintaining gastric health. They exert cytoprotective effects, including increasing bicarbonate secretion, releasing protective mucin, reducing gastric acid output, and preventing harmful vasoconstriction. These effects are mediated through various receptors, such as EP1, EP2, EP3, and EP4.
Non-steroidal anti-inflammatory drugs (NSAIDs) can induce peptic ulcers by inhibiting cyclooxygenase, decreasing...
Non-steroidal anti-inflammatory drugs (NSAIDs) can induce peptic ulcers by inhibiting cyclooxygenase, decreasing...
01:27Ovarian Cycle
The menstrual cycle includes a critical component known as the ovarian cycle, which undergoes two main phases each month—the follicular phase and the luteal phase. The follicular phase is variable and averaging around 14 days. Ovulation, triggered by a surge in luteinizing hormone (LH), marks the transition between the two phases. The second phase, the luteal phase, is relatively consistent, lasting approximately 14 days, and is marked by the activity of the corpus luteum. While a cycle length...
01:22Birth Control Methods
Vasectomy is a surgical form of male sterilization that involves severing and sealing the vasa deferentia, preventing sperm from mixing with semen during ejaculation. Because a vasectomy does not impact the testes' ability to produce testosterone, hormone levels, libido, and sexual function generally remain unchanged. While vasectomy is highly effective in preventing pregnancy, with a success rate near 99.85%, rare cases of recanalization (spontaneous reconnection) can occur. Although vasectomy...
01:21Intrauterine Drug Delivery Systems
Controlled-release systems for intravaginal and intrauterine drug delivery have been developed primarily for the administration of contraceptive steroid hormones. These delivery routes circumvent first-pass hepatic metabolism, thereby enhancing bioavailability and allowing for reduced systemic dosages compared to oral administration. Such approaches contribute to improved therapeutic efficacy and patient compliance, particularly in long-term contraceptive regimens.Intravaginal Drug Delivery...